Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018

To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris;...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial resistance & infection control 2020-06, Vol.9 (1), p.82-82, Article 82
Hauptverfasser:	Garcia-Jeldes, Hector Felipe, Mitchell, Robyn, McGeer, Allison, Rudnick, Wallis, Amaratunga, Kanchana, Vallabhaneni, Snigdha, Lockhart, Shawn R, Bharat, Amrita
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Aged Alberta Anopheles Bacterial Proteins - metabolism beta-Lactamases - metabolism British Columbia Canada Canada - epidemiology Candida Candida - isolation & purification Candida - metabolism Candidiasis - epidemiology Cross infection Disease control Drug resistance Female Fungal infections Genomes Health aspects Health care Hospitals Humans India Intensive care Male Middle Aged Nosocomial infections Ontario Patients Prevalence Quebec Risk factors Short Report Surveillance Transplants & implants Travel
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To identify the prevalence of C. auris in Canadian patients who are potentially at risk for colonization, we screened 488 patients who were either hospitalized abroad, had a carbapenemase-producing organism (CPO), or were in units with high antifungal use. Two patients were colonized with C. auris; both had received healthcare in India and had a CPO. Among 35 patients who had recently received healthcare in the Indian subcontinent and were CPO colonized or infected, the prevalence of C. auris was 5.7%.
ISSN:	2047-2994 2047-2994
DOI:	10.1186/s13756-020-00752-3